|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5919816A
(en)
*
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20020155999A1
(en)
*
|
1998-04-30 |
2002-10-24 |
Han In Suk |
Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
|
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
|
US6075053A
(en)
*
|
1999-02-09 |
2000-06-13 |
Bionumerik Pharmaceuticals, Inc. |
Method of reducing or reversing neuropathy
|
|
US6197831B1
(en)
*
|
1999-02-09 |
2001-03-06 |
Bionumerik Pharmaceuticals, Inc. |
Method of treating septic shock
|
|
US6395481B1
(en)
*
|
1999-02-16 |
2002-05-28 |
Arch Development Corp. |
Methods for detection of promoter polymorphism in a UGT gene promoter
|
|
US20030036513A1
(en)
*
|
1999-02-16 |
2003-02-20 |
Yurkow Edward J. |
Method for treating cancer
|
|
GB9904386D0
(en)
*
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
|
US6664288B1
(en)
*
|
1999-04-14 |
2003-12-16 |
Dana Farber Cancer Institute, Inc. |
Method and composition for the treatment of cancer
|
|
US20050192360A1
(en)
*
|
1999-04-14 |
2005-09-01 |
Li Chiang J. |
Method of treatment of pancreatic cancer
|
|
US20050222246A1
(en)
*
|
1999-04-14 |
2005-10-06 |
Li Chiang J |
Beta-lapachone is a broad spectrum anti-cancer agent
|
|
WO2000064437A1
(en)
*
|
1999-04-22 |
2000-11-02 |
American Biosciences, Inc. |
Long term administration of pharmacologically active agents
|
|
MY164077A
(en)
*
|
1999-05-13 |
2017-11-30 |
Pharma Mar Sa |
Compositions and uses of et743 for treating cancer
|
|
US6034126A
(en)
*
|
1999-05-24 |
2000-03-07 |
Bionumerik Pharmaceuticals, Inc. |
Method for treating glycol poisoning
|
|
GB9916882D0
(en)
*
|
1999-07-19 |
1999-09-22 |
Pharmacia & Upjohn Spa |
Antitumor synergistic composition
|
|
US6294546B1
(en)
*
|
1999-08-30 |
2001-09-25 |
The Broad Of Trustees Of The Leland Stanford Junior University |
Uses of diterpenoid triepoxides as an anti-proliferative agent
|
|
HK1049787B
(en)
|
1999-10-01 |
2014-07-25 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
EP1231984A1
(en)
*
|
1999-11-15 |
2002-08-21 |
Parker Hughes Institute |
Phorboxazole derivatives for treating cancer
|
|
US6890946B2
(en)
*
|
1999-12-23 |
2005-05-10 |
Indiana University Research And Technology Corporation |
Use of parthenolide to inhibit cancer
|
|
WO2001070220A1
(en)
*
|
2000-03-22 |
2001-09-27 |
Neopharm, Inc. |
A method of administering liposomal encapsulated taxane
|
|
GB0011927D0
(en)
*
|
2000-05-17 |
2000-07-05 |
Inst Biomar Sa |
New use of citreamicins
|
|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US20050197405A1
(en)
*
|
2000-11-07 |
2005-09-08 |
Li Chiang J. |
Treatment of hematologic tumors and cancers with beta-lapachone, a broad spectrum anti-cancer agent
|
|
MXPA03004095A
(es)
|
2000-11-09 |
2004-09-10 |
Neopharm Inc |
Complejos de sn-38 con lipidos y sus metodos de uso.
|
|
US6620843B2
(en)
*
|
2001-01-19 |
2003-09-16 |
Pharmagenesis |
Anticancer treatment using triptolide prodrugs
|
|
AU2002251763B2
(en)
*
|
2001-01-19 |
2006-05-04 |
Bionumerik Pharmaceuticals, Inc. |
Method for treating cancer
|
|
US20030149096A1
(en)
*
|
2001-02-05 |
2003-08-07 |
Pezzuto John M. |
Cancer chemopreventative compounds and compositions and methods of treating cancers
|
|
HUP0303466A3
(en)
*
|
2001-03-06 |
2005-02-28 |
Bristol Myers Squibb Company P |
Method and dosage form for treating tumors by administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
|
|
SI1372650T1
(sl)
*
|
2001-03-19 |
2009-04-30 |
Novartis Ag |
Kombinacije, ki obsegajo antidiaroično sredstvo in epotilon ali epotilonski derivat
|
|
US6756063B2
(en)
*
|
2001-03-29 |
2004-06-29 |
Zoltan Laboratories, Llc |
Methods and compositions for the treatment of human and animal cancers
|
|
US7053072B2
(en)
|
2001-05-11 |
2006-05-30 |
Medimmune Oncology, Inc. |
Methods for the administration of amifostine and related compounds
|
|
US20030045515A1
(en)
*
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
US8048917B2
(en)
*
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6476068B1
(en)
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
|
US6596320B1
(en)
*
|
2002-01-11 |
2003-07-22 |
Bionumerik Pharmaceuticals, Inc. |
Method for treating cancer having greater efficacy and reduced adverse effects
|
|
US6816571B2
(en)
*
|
2002-02-06 |
2004-11-09 |
L-3 Communications Security And Detection Systems Corporation Delaware |
Method and apparatus for transmitting information about a target object between a prescanner and a CT scanner
|
|
WO2003077947A1
(en)
|
2002-03-15 |
2003-09-25 |
Schering Corporation |
Methods of modulating cd200 receptors
|
|
US8710095B2
(en)
*
|
2002-04-30 |
2014-04-29 |
Bionumerik Pharmaceuticals, Inc. |
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
|
|
JP4625694B2
(ja)
*
|
2002-05-17 |
2011-02-02 |
レオ ファーマ アクティーゼルスカブ |
シアノグアニジンプロドラッグ
|
|
US7253193B2
(en)
*
|
2002-05-17 |
2007-08-07 |
Leo Pharma A/S |
Cyanoguanidine prodrugs
|
|
WO2003097602A1
(en)
*
|
2002-05-17 |
2003-11-27 |
Leo Pharma A/S |
Cyanoguanidine produgs
|
|
US20040038904A1
(en)
*
|
2002-05-21 |
2004-02-26 |
Angela Ogden |
Method of treating multiple sclerosis
|
|
US7847109B2
(en)
*
|
2002-05-31 |
2010-12-07 |
Pharmagenesis, Inc. |
Triptolide derivatives for modulation of apoptosis and immunosuppression
|
|
AU2003261354A1
(en)
*
|
2002-08-02 |
2004-02-23 |
The Regents Of The University Of California |
New uses for inhibitors of inosine monophosphate dehydrogenase
|
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
US20050272698A1
(en)
*
|
2002-09-05 |
2005-12-08 |
Daftary Gautam V |
Liquid stable composition of oxazaphosphorine with mesna
|
|
US7025745B2
(en)
*
|
2002-10-07 |
2006-04-11 |
Advanced Cardiovascular Systems, Inc. |
Method of making a catheter balloon using a tapered mandrel
|
|
WO2004054569A1
(en)
*
|
2002-12-16 |
2004-07-01 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
|
|
US20040203034A1
(en)
*
|
2003-01-03 |
2004-10-14 |
The University Of Chicago |
Optimization of cancer treatment with irinotecan
|
|
JP4711947B2
(ja)
*
|
2003-02-03 |
2011-06-29 |
ネオファーム、インコーポレイティッド |
安定な濾過滅菌性リポソームに被包化されたタキサン及び他の抗腫瘍剤
|
|
ES2308208T3
(es)
*
|
2003-05-30 |
2008-12-01 |
University Of Chicago |
Metodos y composiciones para predecir la toxicidad del irinotecano.
|
|
US20040266808A1
(en)
*
|
2003-06-27 |
2004-12-30 |
Kamen Barton A. |
Treatment of antifolate neurotoxicity
|
|
DK2263694T3
(da)
*
|
2003-09-25 |
2013-08-26 |
Astellas Pharma Inc |
Antitumormiddel omfattende histon-deacetylase-inhibitoren FK228 og topoisomerase-II-inhibitoren doxorubicin
|
|
US7820834B2
(en)
*
|
2003-12-24 |
2010-10-26 |
Pharmagenesis, Inc. |
Triptolide 5,6-derivatives as immunomodulators and anticancer agents
|
|
WO2005077008A2
(en)
*
|
2004-02-09 |
2005-08-25 |
Pharmagenesis, Inc. |
Methods for isolation of triptolide compounds from tripterygium wilfordii
|
|
US20050187288A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Chiang Li |
Beta-lapachone and methods of treating cancer
|
|
US20050192247A1
(en)
*
|
2004-02-23 |
2005-09-01 |
Li Chiang J. |
Method of treating cancers
|
|
ATE554758T1
(de)
*
|
2004-03-02 |
2012-05-15 |
Pharmagenesis Inc |
Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs
|
|
US20090247475A1
(en)
*
|
2004-03-05 |
2009-10-01 |
The Regents Of The University Of California |
Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies
|
|
US7200207B2
(en)
*
|
2004-03-13 |
2007-04-03 |
Intrado Inc. |
Communication network for providing emergency services
|
|
WO2005094282A2
(en)
*
|
2004-03-26 |
2005-10-13 |
Vion Pharmaceuticals, Inc. |
Combination therapy comprising cloretazinetm
|
|
US20050256055A1
(en)
*
|
2004-05-12 |
2005-11-17 |
Hausheer Frederick H |
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
|
|
US20090111735A1
(en)
*
|
2004-05-12 |
2009-04-30 |
Bionumerik Pharmaceuticals, Inc. |
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
|
|
JP4433918B2
(ja)
*
|
2004-07-15 |
2010-03-17 |
コニカミノルタエムジー株式会社 |
画像形成方法
|
|
ATE552233T1
(de)
*
|
2004-08-20 |
2012-04-15 |
Univ Virginia Patent Found |
T-typ-calciumkanalinhibitoren
|
|
US20060063742A1
(en)
*
|
2004-09-21 |
2006-03-23 |
Hausheer Frederick H |
Method of treatment for or protection against lymphedema
|
|
TWI366459B
(en)
*
|
2004-09-28 |
2012-06-21 |
Ind Tech Res Inst |
Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
|
|
US8617906B2
(en)
*
|
2004-10-13 |
2013-12-31 |
Pharmagenesis, Inc. |
Identification and screening of triptolide target molecules
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
ES2572777T3
(es)
*
|
2004-12-22 |
2016-06-02 |
Leo Pharma A/S |
Compuestos novedosos de cianoguanidina
|
|
EP1790343A1
(en)
*
|
2005-11-11 |
2007-05-30 |
Emotional Brain B.V. |
Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
|
|
AU2006326442B2
(en)
*
|
2005-12-13 |
2012-03-01 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods and compositions
|
|
US8143236B2
(en)
*
|
2005-12-13 |
2012-03-27 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods
|
|
US8895531B2
(en)
*
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
RU2009133447A
(ru)
*
|
2007-02-09 |
2011-03-20 |
Пониард Фармасьютикалз, Инк. (Us) |
Дозированная форма пикоплатина
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
CN101657203B
(zh)
*
|
2007-03-02 |
2012-09-05 |
卧龙岗大学 |
抗癌药的组合物及递送方法
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
|
JP2010533714A
(ja)
*
|
2007-07-16 |
2010-10-28 |
ポニアード ファーマシューティカルズ, インコーポレイテッド |
ピコプラチンのための経口製剤
|
|
WO2009072004A2
(en)
*
|
2007-09-26 |
2009-06-11 |
Gemin X Pharmaceuticals Canada, Inc. |
Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
|
|
JP5696266B2
(ja)
*
|
2007-11-20 |
2015-04-08 |
ランケナー インスティテュート フォー メディカル リサーチ |
ジスルフィド化学療法剤およびその使用方法
|
|
CN102006875A
(zh)
*
|
2008-02-08 |
2011-04-06 |
帕纳德制药公司 |
吡铂和贝伐单抗治疗结直肠癌的用途
|
|
CN104667279B
(zh)
|
2008-03-03 |
2018-10-26 |
托斯克公司 |
减少毒性的甲氨蝶呤佐剂及其使用方法
|
|
WO2009111648A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Vicus Therapeutics, Llc |
Compositions and methods for mucositis and oncology therapies
|
|
EP2252246B1
(en)
*
|
2008-03-14 |
2014-06-18 |
Bionumerik Pharmaceuticals, Inc. |
Chemoprotective methods and compositions
|
|
US9320760B2
(en)
*
|
2008-03-14 |
2016-04-26 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
|
EP2249825B1
(en)
*
|
2008-03-14 |
2015-10-07 |
Bionumerik Pharmaceuticals, Inc. |
Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
|
|
AU2008352603B2
(en)
*
|
2008-03-14 |
2012-05-31 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
|
WO2010132771A1
(en)
|
2009-05-15 |
2010-11-18 |
Lankenau Institute For Medical Research |
Methods and kits for measuring toxicity and oxidative stress in live cells
|
|
CA2787673A1
(en)
|
2010-03-01 |
2011-09-09 |
Tau Therapeutics Llc |
Cancer diagnosis and imaging
|
|
CN103221388B
(zh)
*
|
2010-07-09 |
2016-09-28 |
维理生物技术公司 |
用于抑制转移性肿瘤生长的新型磺酰胺化合物
|
|
US9271952B2
(en)
*
|
2011-10-11 |
2016-03-01 |
Complexa, Inc. |
Compositions and methods for treating nephropathy
|
|
CN102871991B
(zh)
*
|
2012-10-24 |
2014-06-18 |
中国医学科学院放射医学研究所 |
二甲双胍在对放化疗损伤起保护作用的药物中的应用
|
|
EP3027212A1
(en)
*
|
2013-08-02 |
2016-06-08 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
US9470029B2
(en)
|
2014-05-30 |
2016-10-18 |
Pella Corporation |
Casement pivot arm roller hinge
|
|
HRP20210543T1
(hr)
|
2015-07-07 |
2021-05-14 |
H. Lundbeck A/S |
Inhibitori pde9 s imidazo triazinonskom okosnicom i imidazo pirazinonskom okosnicom za liječenje perifernih bolesti
|
|
MX2018004043A
(es)
|
2015-10-02 |
2018-11-09 |
Complexa Inc |
Prevencion, tratamiento y reversion de enfermedad usando cantidades terapeuticamente efectivas de acidos grasos activados.
|
|
CN112469413B
(zh)
|
2018-05-25 |
2024-01-12 |
伊马拉公司 |
6-[(3s,4s)-4-甲基-1-(嘧啶-2-基甲基)吡咯烷-3-基]-3-四氢吡喃-4-基-7h-咪唑并[1,5-a]吡嗪-8-酮的一水合物和结晶形态
|
|
EP3843737A4
(en)
|
2018-08-31 |
2022-06-01 |
Imara Inc. |
PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE
|